Literature DB >> 20348239

Pathological features of heterologous immunity are regulated by the private specificities of the immune repertoire.

Siwei Nie1, Sue-Jane Lin, Sung-kwon Kim, Raymond M Welsh, Liisa K Selin.   

Abstract

Heterologous immunity associated with cross-reactive T-cell responses is proposed to contribute to variations among individuals in the pathogenesis of human viral infections. In genetically identical mice with similar infection histories, marked variations in the magnitude and specificities of T-cell responses under conditions of heterologous immunity occur and have been linked to the private specificity of T-cell repertoires in individual immune mice. Variations in immunopathology in the form of panniculitis are observed in lymphocytic choriomeningitis virus-immune mice after vaccinia virus infection. By adoptively transferring splenocytes from individual lymphocytic choriomeningitis virus-immune donors into paired recipients, we show here that, on vaccinia virus infection, similar levels of panniculitis were generated in recipients from a single donor, but the severity of panniculitis varied among recipients receiving cells from different donors. This indicates that virus-induced immunopathology under conditions of heterologous immunity is a function of the private specificity of the immune repertoire.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20348239      PMCID: PMC2861077          DOI: 10.2353/ajpath.2010.090656

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  17 in total

Review 1.  Dengue: an update.

Authors:  María G Guzmán; Gustavo Kourí
Journal:  Lancet Infect Dis       Date:  2002-01       Impact factor: 25.071

2.  T cell responses to an HLA-B*07-restricted epitope on the dengue NS3 protein correlate with disease severity.

Authors:  Iva Zivna; Sharone Green; David W Vaughn; Siripen Kalayanarooj; Henry A F Stephens; Dasnayanee Chandanayingyong; Ananda Nisalak; Francis A Ennis; Alan L Rothman
Journal:  J Immunol       Date:  2002-06-01       Impact factor: 5.422

3.  T cell immunodominance and maintenance of memory regulated by unexpectedly cross-reactive pathogens.

Authors:  Michael A Brehm; Amelia K Pinto; Keith A Daniels; Jonathan P Schneck; Raymond M Welsh; Liisa K Selin
Journal:  Nat Immunol       Date:  2002-06-03       Impact factor: 25.606

4.  Epidemiologic studies on Dengue in Santiago de Cuba, 1997.

Authors:  M G Guzmán; G Kouri; L Valdes; J Bravo; M Alvarez; S Vazques; I Delgado; S B Halstead
Journal:  Am J Epidemiol       Date:  2000-11-01       Impact factor: 4.897

5.  Risk factors and clinical features associated with severe dengue infection in adults and children during the 2001 epidemic in Chonburi, Thailand.

Authors:  Ole Wichmann; Suchat Hongsiriwon; Chureeratana Bowonwatanuwong; Kesinee Chotivanich; Yoawalark Sukthana; Sasithon Pukrittayakamee
Journal:  Trop Med Int Health       Date:  2004-09       Impact factor: 2.622

6.  Why dengue haemorrhagic fever in Cuba? 1. Individual risk factors for dengue haemorrhagic fever/dengue shock syndrome (DHF/DSS).

Authors:  J R Bravo; M G Guzmán; G P Kouri
Journal:  Trans R Soc Trop Med Hyg       Date:  1987       Impact factor: 2.184

7.  Risk factors in dengue shock syndrome: a prospective epidemiologic study in Rayong, Thailand. I. The 1980 outbreak.

Authors:  N Sangkawibha; S Rojanasuphot; S Ahandrik; S Viriyapongse; S Jatanasen; V Salitul; B Phanthumachinda; S B Halstead
Journal:  Am J Epidemiol       Date:  1984-11       Impact factor: 4.897

8.  Original antigenic sin and apoptosis in the pathogenesis of dengue hemorrhagic fever.

Authors:  Juthathip Mongkolsapaya; Wanwisa Dejnirattisai; Xiao-ning Xu; Sirijitt Vasanawathana; Nattaya Tangthawornchaikul; Aroonrung Chairunsri; Siraporn Sawasdivorn; Thaneeya Duangchinda; Tao Dong; Sarah Rowland-Jones; Pa-thai Yenchitsomanus; Andrew McMichael; Prida Malasit; Gavin Screaton
Journal:  Nat Med       Date:  2003-07       Impact factor: 53.440

9.  Protective heterologous antiviral immunity and enhanced immunopathogenesis mediated by memory T cell populations.

Authors:  L K Selin; S M Varga; I C Wong; R M Welsh
Journal:  J Exp Med       Date:  1998-11-02       Impact factor: 14.307

Review 10.  Pathogenic epitopes, heterologous immunity and vaccine design.

Authors:  Raymond M Welsh; Robert S Fujinami
Journal:  Nat Rev Microbiol       Date:  2007-07       Impact factor: 60.633

View more
  19 in total

Review 1.  Some unmet challenges in the immunology of viral infections.

Authors:  Barry T Rouse; Aron E Lukacher
Journal:  Discov Med       Date:  2010-10       Impact factor: 2.970

Review 2.  The two faces of heterologous immunity: protection or immunopathology.

Authors:  Shalini Sharma; Paul G Thomas
Journal:  J Leukoc Biol       Date:  2013-11-08       Impact factor: 4.962

3.  Antigen-Specificity of T Cell Infiltrates in Biopsies With T Cell-Mediated Rejection and BK Polyomavirus Viremia: Analysis by Next Generation Sequencing.

Authors:  G Zeng; Y Huang; Y Huang; Z Lyu; D Lesniak; P Randhawa
Journal:  Am J Transplant       Date:  2016-07-15       Impact factor: 8.086

4.  The polyomavirus BK large T-antigen-derived peptide elicits an HLA-DR promiscuous and polyfunctional CD4+ T-cell response.

Authors:  Bala Ramaswami; Iulia Popescu; Camila Macedo; Chunqing Luo; Ron Shapiro; Diana Metes; Geetha Chalasani; Parmjeet S Randhawa
Journal:  Clin Vaccine Immunol       Date:  2011-03-02

Review 5.  Heterologous immunity: immunopathology, autoimmunity and protection during viral infections.

Authors:  Liisa K Selin; Myriam F Wlodarczyk; Anke R Kraft; Siwei Nie; Laurie L Kenney; Roberto Puzone; Franco Celada
Journal:  Autoimmunity       Date:  2011-01-20       Impact factor: 2.815

6.  Heterologous Immunity and Persistent Murine Cytomegalovirus Infection.

Authors:  Jenny W Che; Keith A Daniels; Liisa K Selin; Raymond M Welsh
Journal:  J Virol       Date:  2017-01-03       Impact factor: 5.103

Review 7.  Vaccination and heterologous immunity: educating the immune system.

Authors:  Anna Gil; Laurie L Kenney; Rabinarayan Mishra; Levi B Watkin; Nuray Aslan; Liisa K Selin
Journal:  Trans R Soc Trop Med Hyg       Date:  2015-01       Impact factor: 2.184

8.  Anti-IFN-γ and peptide-tolerization therapies inhibit acute lung injury induced by cross-reactive influenza A-specific memory T cells.

Authors:  Myriam F Wlodarczyk; Anke R Kraft; Hong D Chen; Laurie L Kenney; Liisa K Selin
Journal:  J Immunol       Date:  2013-02-13       Impact factor: 5.422

9.  Increased Immune Response Variability during Simultaneous Viral Coinfection Leads to Unpredictability in CD8 T Cell Immunity and Pathogenesis.

Authors:  Laurie L Kenney; Markus Cornberg; Alex T Chen; Sebastien Emonet; Juan Carlos de la Torre; Liisa K Selin
Journal:  J Virol       Date:  2015-08-12       Impact factor: 5.103

10.  CD11c⁺ cells primed with unrelated antigens facilitate an accelerated immune response to influenza virus in mice.

Authors:  Laura E Richert; Agnieszka Rynda-Apple; Ann L Harmsen; Soo Han; James A Wiley; Trevor Douglas; Kyle Larson; Rachelle V Morton; Allen G Harmsen
Journal:  Eur J Immunol       Date:  2014-01-13       Impact factor: 5.532

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.